Avricore Health Inc
8VP1
Company Profile
Business description
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.
Contact
1120 - 789 West Pender Street
VancouverBCV6C 1H2
CANT: +1 778 968-1176
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
1
Stocks News & Analysis
stocks
Tesla: valuation is key consideration in merger talks with SpaceX
We see regulatory risk from both the US and Chinese governments.
stocks
Meta earnings: Early look at Muse adoption impresses investors
We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,926.60 | 20.80 | 0.23% |
| CAC 40 | 7,861.19 | 78.37 | 1.01% |
| DAX 40 | 25,488.50 | 306.85 | 1.22% |
| Dow JONES (US) | 52,459.33 | 244.17 | 0.47% |
| FTSE 100 | 10,762.30 | 71.94 | 0.67% |
| HKSE | 23,211.81 | 118.44 | 0.51% |
| NASDAQ | 26,272.54 | 317.20 | 1.22% |
| Nikkei 225 | 62,189.65 | 503.51 | -0.80% |
| NZX 50 Index | 13,733.93 | 12.91 | -0.09% |
| S&P 500 | 7,695.18 | 71.50 | 0.94% |
| S&P/ASX 200 | 8,809.90 | 14.70 | 0.17% |
| SSE Composite Index | 3,697.52 | 7.04 | 0.19% |